- Home
- THTX vs CSBR Comparison
THTX vs CSBR Comparison
Compare THTX & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- CSBR
- Stock Information
- Founded
- THTX 1993
- CSBR 1985
- Country
- THTX Canada
- CSBR United States
- Employees
- THTX N/A
- CSBR N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- THTX Health Care
- CSBR Health Care
- Exchange
- THTX Nasdaq
- CSBR Nasdaq
- Market Cap
- THTX 144.8M
- CSBR 123.2M
- IPO Year
- THTX N/A
- CSBR 1986
- Fundamental
- Price
- THTX $3.29
- CSBR $8.30
- Analyst Decision
- THTX Hold
- CSBR Strong Buy
- Analyst Count
- THTX 1
- CSBR 1
- Target Price
- THTX N/A
- CSBR $12.00
- AVG Volume (30 Days)
- THTX 372.3K
- CSBR 30.4K
- Earning Date
- THTX 10-09-2025
- CSBR 09-15-2025
- Dividend Yield
- THTX N/A
- CSBR N/A
- EPS Growth
- THTX N/A
- CSBR N/A
- EPS
- THTX N/A
- CSBR 0.33
- Revenue
- THTX $84,378,000.00
- CSBR $56,944,000.00
- Revenue This Year
- THTX N/A
- CSBR $9.30
- Revenue Next Year
- THTX $13.76
- CSBR $31.17
- P/E Ratio
- THTX N/A
- CSBR $24.12
- Revenue Growth
- THTX 2.19
- CSBR 13.54
- 52 Week Low
- THTX $1.12
- CSBR $3.75
- 52 Week High
- THTX $3.31
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- THTX 70.36
- CSBR 68.02
- Support Level
- THTX $3.26
- CSBR $6.33
- Resistance Level
- THTX $3.31
- CSBR $7.25
- Average True Range (ATR)
- THTX 0.02
- CSBR 0.40
- MACD
- THTX -0.00
- CSBR 0.09
- Stochastic Oscillator
- THTX 71.43
- CSBR 81.74
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.